Eisai
4523.T
#2079
Rank
โ‚ฌ8.39 B
Marketcap
29,73ย โ‚ฌ
Share price
6.09%
Change (1 day)
16.16%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): โ‚ฌ0.32 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚ฌ5.44 Billion. In 2025 the company made an earning of โ‚ฌ0.38 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.32 B-15.23%
2025 โ‚ฌ0.38 B-20.48%
2024 โ‚ฌ0.47 B2.42%
2023 โ‚ฌ0.46 B-2404.04%
2022 -โ‚ฌ20.26 Million-103.6%
2021 โ‚ฌ0.56 B-39.81%
2020 โ‚ฌ0.93 B7.44%
2019 โ‚ฌ0.87 B17.22%
2018 โ‚ฌ0.74 B86.16%
2017 โ‚ฌ0.39 B-23.52%
2016 โ‚ฌ0.52 B26.97%
2015 โ‚ฌ0.41 B22.3%
2014 โ‚ฌ0.33 B-46.07%
2013 โ‚ฌ0.62 B-21.85%
2012 โ‚ฌ0.79 B-20.59%
2011 โ‚ฌ1.00 B-8.91%
2010 โ‚ฌ1.10 B19.21%
2009 โ‚ฌ0.92 B